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A B S T R A C T
Low grade, chronic inflammation is a critical risk factor for immunologic dysfunction including autoimmune
diseases. However, the multiplicity of complex mechanisms and lack of relevant murine models limit our un-
derstanding of the precise role of chronic inflammation. To address these hurdles, we took advantage of multi-
omics data and a unique murine model with a low but chronic expression of IFN-γ, generated by replacement of
the AU-rich element (ARE) in the 3’ UTR region of IFN-γ mRNA with random nucleotides. Herein, we demon-
strate that low but differential expression of IFN-γ in mice by homozygous or heterozygous ARE replacement
triggers distinctive gut microbial alterations, of which alteration is female-biased with autoimmune-associated
microbiota. Metabolomics data indicates that gut microbiota-dependent metabolites have more robust sex-dif-
ferences than microbiome profiling, particularly those involved in fatty acid oxidation and nuclear receptor
signaling. More importantly, homozygous ARE-Del mice have dramatic changes in tryptophan metabolism, bile
acid and long-chain lipid metabolism, which interact with gut microbiota and nuclear receptor signaling simi-
larly with sex-dependent metabolites. Consistent with these findings, nuclear receptor signaling, encompassing
molecules such as PPARs, FXR, and LXRs, was detectable as a top canonical pathway in comparison of blood and
tissue-specific gene expression between female homozygous vs heterozygous ARE-Del mice. Further analysis
implies that dysregulated autophagy in macrophages is critical for breaking self-tolerance and gut homeostasis,
while pathways interact with nuclear receptor signaling to regulate inflammatory responses. Overall, pathway-
based integration of multi-omics data provides systemic and cellular insights about how chronic inflammation
driven by IFN-γ results in the development of autoimmune diseases with specific etiopathological features.
1. Introduction
Chronic inflammation lasts for several months to years and is as-
sociated with the most prevalent worldwide diseases, including
autoimmune diseases [1]. Due to increases in obesity, population aging
and environmental toxins as high-risk factors for chronic inflammation,
more attention has been focused on understanding the etiological me-
chanisms that trigger chronic inflammation as well as defining its role
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in disease. However, understanding the links between etiological and
pathological features are poorly defined due to the complexity of the
biological processes. Chronic inflammation and autoimmune diseases
link together bi-directionally [2]; chronic inflammatory autoimmune
disorders result in the production of cytokines and chemokines, which
further lead to additional chronic inflammation-mediated disorders.
Furthermore, prolonged inflammation, e.g. as a result of failing to clear
pathogens, may trigger the development of autoimmune diseases [3].
One example of the consequences of cytokine dysregulation is the
constant expression of interferons. Interferons are produced by immune
cells to defend against infection and can act as antimicrobial and an-
tiviral agents [4].
Chronic expression of interferons is seen in various autoimmune
diseases including SLE, RA, and Sjogren's Syndrome [5,6], but the pa-
thological mechanisms controlling interferon expression in auto-
immune diseases is still not well understood. We recently engineered a
murine model of chronic inflammation as a result of a low, persistent
expression of interferon-gamma (IFN-γ) that mimics chronic in-
flammatory conditions in humans, through substitution of the AU-rich
element (ARE) in the IFN-γ 3′ untranslated region (coined ARE-Del)
with random nucleotides which results in low but chronic expression of
IFN-γ [7]. We observed that the ARE-Del mice have autoimmune
manifestations with striking clinical, immunological and histopatholo-
gical characteristics of human primary biliary cirrhosis (PBC) with a
female prevalence [8,9]. As major autoimmune diseases including SLE,
RA, Sjogren's syndrome, and PBC have a high incidence in women [10],
the mechanistic understanding of female-biased inflammatory re-
sponses is pivotal for the treatment of autoimmune diseases. Therefore,
this model can be utilized for developing a mechanistic understanding
of how chronic inflammation leads to autoimmune diseases.
Pathway-based analysis, known as a functional enrichment analysis
focusing on biological functions, is a valuable tool to integrate multi-
omics studies [11,12]. Particularly, immune responses are rapidly
processed by post-transcriptional or post-translational modification
[13,14], thus pathway analysis rather than individual gene signatures
provide more adequate information for predicting immune responses.
For example, even when individual gene expression levels (e.g. cyto-
kines and surface markers) are not observed to be changed, their acti-
vation can be inferred by down-stream or correlated pathways. Here we
present how we applied this tool to integrate different types of data sets
and characterize target pathways and molecules in the immune system
of mice.
Homozygous or heterozygous alleles at the IFN-γ locus result in
differing levels of circulating IFN-γ [7]. The average serum level of IFN-
γ in homozygous ARE-Del mice was measured to be ~30 pg/ml, com-
pared to negligible levels of control mice, while heterozygous ARE-Del
mice have generally less than ~15 pg/ml. Further, we characterized
that the serum level of IFN-γ was more strongly expressed in female
than male ARE-Del mice [8]. Phenotypically, both genotypes share si-
milarities with respect to human PBC, such as portal lymphocytic in-
filtration and anti-mitochondrial antibody (AMA) production. Whereas,
there are distinctive pathological and serological features, including
loss of marginal zone B cells (MZB), increases of germinal center (GC) B
cells and antinuclear antibody (ANA) production, specifically observed
in homozygous ARE-Del mice. Based on our previous report that de-
pletion of macrophages by clodronate liposomes (CLL) in heterozygous
ARE-Del mice significantly increases the pathological phenotypes ob-
served in homozygous ARE-Del mice, herein we focused on macrophage
function and the mechanistic differences between heterozygous vs
homozygous ARE-Del mice.
2. Materials and methods
2.1. Animals
ARE-Del mice were generated and maintained as previously
reported [7,8]. Animal care was provided in accordance with the
“Guide for Care and Use of Laboratory Animals” (National Research
Council; 2011; National Academy Press: Washington, D.C.). The ex-
perimental protocols were approved by National Cancer Institute at
Frederick and the University of California at Davis Animal Care and Use
Committees. All experiments were performed in group sizes of 4–6, and
the numbers in each experiment are noted in the figure legends.
2.2. Cecum microbiome analysis
The cecum microbiome composition of homozygous and hetero-
zygous ARE-Del mice and control littermates at 4, 8 and 20 weeks of
age were examined. Briefly, a harvested cecum section was rapidly
frozen in dry ice and stored in −80 °C. Immediately after thawing, DNA
was isolated using a Powersoil DNA isolation kit (MO Bio, CA), quan-
tified and stored at −20 °C. The V4 region of the 16S rDNA gene (515F-
806R) was sequenced; generating partially overlapping, paired-end
reads on the Illumina MiSeq platform. The demultiplexed paired-end
fastq files were pre-processed and analyzed using QIIME2 [15]. The
DADA2 algorithm [16] implemented in QIIME2, was used for error
modeling and filtering the raw fastq files. After denoising and chimera
removal; a total of 1,656,000 sequences were retained for 51 samples.
The taxonomic classification was performed using the QIIME2 feature-
classifier plugin trained on the Silva 132 database [17]. The Alpha and
Beta-diversity analyses were performed using the diversity plugin at a
sampling depth of 24,000 reads per sample. Alpha diversity was cal-
culated by Shannon's diversity index and observed operational taxo-
nomic units (OTUs). Principal coordinate analysis (PCoA) was per-
formed to calculate Beta diversity using Bray-Curtis distances, and
pairwise Permutational Multivariate Analysis of Variance (PERMAN-
OVA) was used to analyze statistical differences in beta diversity with
QIIME2.
2.3. Blood and tissue-specific gene expression analysis
For global gene expression analysis, spleen, thymus, kidney, and
blood were harvested from 3, 6 and 12-week old homozygous and
heterozygous ARE-Del mice compared to control littermates (Each
group has at least three replicates and total sample numbers are 218).
To extract RNA from the spleen, thymus, and kidney, 1 ml of Trizol per
50–100 mg of tissue was homogenized with a TissueRuptor (Qiagen).
RNA samples were prepared by the conventional phenol-chloroform
RNA extraction. To prepare RNA from peripheral blood mononuclear
cells (PBMCs), approximately 1 ml of blood per mouse were collected
by cardiac puncture under anesthesia and diluted 1:1 with PBS. PBMCs
were then obtained by gradient centrifugation using sterile-filtered
histopaque 1077 (Sigma), washed and resuspended in sterile PBS. RNA
was then purified as above using 10X volume of Trizol to cell ratio. RNA
was quantified by Nanodrop (Thermo Scientific) and assessed by
Bioanalyzer 2100 (Agilent Technologies). Transcriptional differences
between homozygous and heterozygous ARE-Del mice were compared
with control littermates using microarray analysis. Briefly, Cy3-labeled
complementary DNA was generated using the Low Input Quick Amp
Labeling Kit, one-color (Agilent Technologies) and hybridized to a
custom 180k Agilent array with the content of the Human Gene
Expression 44K replicated four times (AMADID#026822; Agilent
Technologies). Analyses were conducted with log2‐transformed in-
tensities that had been normalized at the array level to have a com-
parable intensity spectrum. Further statistical analysis of homozygous
ARE-Del mice, heterozygotes with control littermates in each tissue and
age was performed by Partek Genomics Suite 6.6 (v6.14.006).
2.4. Plasma metabolome analysis
Plasma was collected from 16 weeks old male and female homo-
zygous ARE-Del mice (each n = 6, total n = 12) and control littermates
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(each n = 6, total n = 12), and stored at −80 °C. Metabolome analysis
was performed at Metabolon, Inc (Durham, NC), as previously de-
scribed [18]. Briefly, sample preparation was conducted using a pro-
prietary series of organic and aqueous extractions to remove the protein
fraction while allowing maximum recovery of small molecules. Each
sample was then frozen and dried under vacuum. Samples were then
prepared for the appropriate instrument, either LC/MS or GC/MS. The
LC/MS portion of the platform was based on a Waters Acquity UPLC
and a Thermo-Finnigan LTQ-FT mass spectrometer, which consists of an
electrospray ionization (ESI) source and a linear ion-trap (LIT) front end
and a Fourier transform ion cyclotron resonance (FT-ICR) mass spec-
trometer backend. Fragmentation spectra (MS/MS) was employed, such
as in the case of lower level signals. One aliquot was analyzed using
acidic positive ion optimized conditions and the other using basic ne-
gative ion optimized conditions in two independent injections using
separate dedicated columns. Extracts reconstituted in acidic conditions
were gradient eluted using water and methanol both containing 0.1%
formic acid, while the basic extracts, which also used water/methanol,
contain 6.5 mM ammonium bicarbonate. The samples destined for GC/
MS analysis were re-dried under vacuum desiccation for a minimum of
24 h prior to being derivatized under dried nitrogen using bistrimethyl-
silyl-triflouroacetamide (BSTFA). The GC column was 5% phenyl and
the temperature ramp was from 40° to 300 °C in a 16 min period.
Samples were analyzed on a Thermo-Finnigan Trace DSQ fast-scanning
single-quadrupole mass spectrometer using electron impact ionization.
For data analysis including the data extraction, quality control, com-
pound identification, curation, and normalization, we used instrument
vendor-supplied or in-house software.
2.5. MicroRNA expression data analysis
Total RNA enriched with miRNA from the thymus was extracted
using miRNeasy Mini Kit (Qiagen, Hilden, Germany) following the
manufacturer's protocol. 100 ng of RNA was used as input for the
NanoString platform (Nanostring, Seattle, WA). DNA sequences called
miRtags were ligated to the mature miRNAs and unligated miRtags
were removed by enzymatic purification. The miRtagged mature
miRNA was hybridized with a nCounter miRNA Expression Assay
CodeSet overnight at 65 °C. The unhybridized CodeSet was eliminated
by automated purification on a nCounter Prep station, and the hy-
bridized CodeSet was analyzed and raw data were collected through a
nCounter Digital Analyzer. Data normalization was performed on
nSolver and differentially expressed miRNAs were analyzed by Partek
Genomics Suite.
2.6. Detection of autophagosome formation
Female homozygous ARE-Del and control littermates were used to
isolate bone marrow cells which were flushed from the femur and tibia.
To differentiate bone marrow-derived macrophages, cells were cultured
with 25 ng/ml murine GM-CSF (Miltenyi Biotech) for 7–10 days.
Attached cells were further isolated to measure autophagosomes using
Cyto-ID detection kit (Enzo Life Sciences, Farmingdale, NY), which has
a cationic amphiphilic tracer dye to stain selectively autophagic va-
cuoles. Briefly, cells were treated with 3 μM rapamycin and incubated
at 37 °C for 2 h. Cells were collected after PBS washing and incubated
for 30 min with the detection reagent containing dyes for autophagic
vacuoles and nuclear (Hoechst 33,342). After PBS washes, the cells
were fixed with 4% paraformaldehyde for 20 min in the dark and im-
mediately pictured under a Leica TCS SP8 laser scanning confocal mi-
croscope with a 63X objective.
3. Results
3.1. Cecal microbiota are distinctively altered by low, but differential levels
of IFNγ
To investigate whether low but chronic expression of IFN-γ affects
the gut microbiome, we performed 16S rRNA analysis on cecum mi-
crobial populations between sample groups of homozygous, hetero-
zygous ARE-Del mice, and control littermates at 4, 8, and 20 weeks of
age. Cecal microbial profiling demonstrated that there are distinct
differences in the diversity and richness in cecum bacterial populations
between these mice. The observed OTUs and Shannon index indicate
that there was a significant alteration in homozygotes when compared
with heterozygotes and control mice (Fig. 1A), while there were no
significant changes of these indexes between age groups (Fig. 1B).
Consistently, the microbial beta diversity represented by PCoA plots
with Pairwise Permanova, demonstrated that homozygous ARE-Del
mice cluster significantly differently (p < 0.05) from heterozygotes
and the control group on axis 1 (17.6%) (Fig. 1C). Although there was a
slight diversity in the PCoA plot demonstrating different age groups
(Fig. 1D), all pairwise adjusted p values between age groups were<
0.05, indicating age-related changes in the gut microbiome. Significant
changes (p < 0.05) in microbiota amongst ARE-Del homo-, hetero-
zygotes, and wild type at the genus level are represented as heat maps,
which were separated by log2 fold changes (0–5 and 5 to 10) (Fig. 1E).
The pattern of changes in homozygous ARE-Del was generally reduced
when compared to heterozygous ARE-Del and control littermates, in-
dicating the lower microbial diversity in homozygous ARE-Del mice as
one of makers for gut dysbiosis. Notably, homozygous mice specifically
increased genera, including Desulfovibrio, Roseburia, and Alistipes, that
have been associated with various autoimmune diseases.
3.2. Sex-difference in gut dysbiosis with autoimmune disease-associated gut
microbiota
Although sex-specific microbial profiles have been reported in
human and various mouse strains, it is not well understood whether
sex-specific microbial profiles are associated with the development of
autoimmune diseases. Thus, we further analyzed microbial changes at
the genus level to examine the difference between male and female
homozygous ARE-Del mice (Fig. 2). Although the observed OTUs and
Shannon index (Fig. 2A) and beta diversity (Fig. 2B) were not sig-
nificantly different between male and female homozygous ARE-Del
mice, there were statistically significant (p < 0.05) diversities when
Fig. 1. Comparison of cecal microbial profiles from homozygous and heterozygous ARE-Del mice. (A) Boxplots of observed OTUs richness and Shannon diversity
indexes comparing cecum samples from homozygous (n = 27) and heterozygous (n = 17) ARE-Del mice with control littermates (n = 24) at 20 weeks old. Kruskal-
Wallis test was performed to analyze the significance (***p < 0.0001). (B) Boxplots of observed OTUs richness and Shannon diversity indexes comparing different
ages of 4 weeks (n = 17), 8 weeks (n = 13) and 20 weeks (n = 39). (C) A PCoA plot of cecum samples from homozygous (KO) and heterozygous (Het) mice with
control littermates (WT). (D) A PCoA plot of cecum samples collected at 4, 8 and 20 weeks of age. (C–D) Pairwise Permanova was also used to estimate beta group
significance. (E) Heat map of relative expression values of normalized counts for the significant changes (p < 0.05) at the genus level in female and male
homozygous and heterozygous ARE-Del mice compared to control littermates.
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male and female mice were separately analyzed at the genus level
(Fig. 2C). Female homozygous ARE-Del mice had significantly in-
creased genera of Alistipes, ASF356, Desulfovibrio, Lachnospiraceae UCG-
010, Mucispirillum, Ruminococcus 1, Trichomonas, and Tyzzerella 3.
However, Alloprevotella, Christensenellaceae R-7 group, GCA-900066575,
Lachnospiraceae FCS020 group, Muribaculum, Oscillibacter, Parasutterella,
Prevotellaceae UCG-001, Rikenellaceae RC9, Ruminiclostridium, Rumi-
nislostridium 5, Ruminislostridium 6, Ruminislostridium 9, Ruminococca-
ceae UCG-005, and Ruminococcaceae UCG-014 were less abundant in
female homozygous ARE-Del mice than control littermates. In male
homozygous ARE-Del mice, Lachnospiraceae UCG-001, Lachnospiraceae
UCG-010, Tritrichomonas, and Tyzzerella 4 significantly increased, while
the abundance of Alloprevotella, GCA-900066575, Lachnospiraceae UCG-
006, Parabacteroides, Rikenellaceae RC9 gut group, and Ruminislostridium
6 were suppressed.
3.3. Robust sex differences in energy and lipid metabolism in homozygous
ARE-Del mice, associated with the gut microbiome and nuclear receptor
signaling
As cecal microbiome was strongly changed as early as 4 weeks old in
homozygous ARE-Del mice, we thus further analyzed metabolomics
profiles in the plasma at 4 weeks of age between male and female
homozygous ARE-Del mice compared to control littermates. This
Fig. 2. Sex-specific cecal microbial profiles in homozygous ARE-Del mice. (A) Boxplots of observed OTUs richness and Shannon diversity indexes and (B) A PCoA plot
comparing cecum samples from female (n = 40) and male (n = 29) mice (all genotypes combined). (C) Bar graphs of sex-specific intestinal bacteria at the genus
level. The upper graph presents significantly changed bacteria between female homozygous ARE-Del mice (F_KO) and control female littermates (F_WT). The lower
graph presents data comparing male homozygous ARE-Del mice (M_KO) and control male littermates (M_WT). The abundance of genera was converted into log fold
ratio (Log2) and each bar shows mean with SEM. Statistical analysis is performed by multiple t-test (no multiple comparisons), *P < 0.05, **P < 0.001,
***P < 0.001.
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Table 1
Representative average fold changes of serum metabolites in male and female homozygous ARE-Del mice compared to control wild-type mice. Significant fold
changes are marked by red and green colors (p < 0.05). All KO; both male and female homozygous ARE-Del mice (n = 12) vs control littermates (n = 12), KO F;
female homozygous ARE-Del mice (n = 6) vs control littermates (n = 6), KO M; male homozygous ARE-Del mice (n = 6) vs control littermates (n = 6).
(continued on next page)
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analysis not only explored the interplay between the gut microbiome
and host metabolism but also characterized sex different metabolic
processes. Table 1 lists overall metabolic changes observed between
female vs male ARE-Del mice compared to control littermates at 4
weeks of age as described in the methods section. Each value represents
the relative expression ratio transformed to log2 scale, and significantly
(p < 0.05) up- or down-regulated changes are marked as a red or
green color, respectively. Notable changes in both male and female
homozygous ARE-Del mice included tryptophan metabolism, bile acid
and long-chain lipid metabolism, and gamma-glutamyl transferred
peptides. Principal component analysis (PCA) revealed robust sex dif-
ferences between male vs female in both homozygous ARE-Del mice
and control littermates (Fig. 3A). Genotypes also strongly affected
metabolic profiling, while genotype difference was relatively greater in
female than male mice. In detail, changes of identified metabolites in
male and female homozygous ARE-Del mice were compared by the
positive correlation of a scatter plot (Fig. 3B). Strong sex-difference was
detectable in three notable areas (marked as red circles) based on
correlated metabolites. p-cresol sulfate and 4-ethylphenylsulfate,
known as microbial metabolites [19,20], were more significantly al-
tered in male than female ARE-Del mice. Other two notable areas in-
clude metabolites associated with fatty acid oxidation (FAO) and tauro-
conjugated bile acids. As overall fold changes were stronger in female
ARE-Del mice, mostly located between +1 and −1 relative fold ratio
(dotted lines), metabolites with sex-differences are shown in Fig. 3C.
Robust sex-differences were visible in amino acid metabolisms in-
cluding glycine, phenylalanine, tyrosine, and tryptophan metabolism as
well as urea cycle. Considering that most of these metabolites contain
an aromatic ring, sex-different metabolic processes are likely involved
in nuclear receptor-mediated metabolic pathways such as mitochon-
drial fatty acid oxidation.
As shown in Fig. 3D and E, the basal expression levels of hex-
anoylglycine and 3-hydroxybutyrate were higher in female wild type
mice than male mice. Furthermore, the basal level of hexanoylglycine
was dramatically suppressed only in female homozygous ARE-Del mice.
Not only mitochondiral fatty acid oxidation but other mitochondrial
energy metabolic processes were significantly altered with an observed
sex-difference. Metabolites linked to these pathways include female-
specific increases of succinate and ribulose in homozygous ARE-Del
mice (Supplemental Figs. 2A and 2B). Analysis of bile acid composition
in homozygous ARE-Del mice demonstrated that tauro-conjugated bile
acids including tauro-beta muricholate, taurochenodeoxycholate,
taurocholate, and taurodeoxycholate were higher in female than male
homozygous ARE-Del mice, while non-conjugated bile acids such as
deoxycholate, cholate, beta-muricholate are higher in male homo-
zygous ARE-Del mice (Fig. 3F). Further, we compared the ratio of each
tauro-conjugated vs non-conjugated bile acid and the most notable
difference was found in tauro-beta-muricholate, a natural FXR an-
tagonist, between male and female ARE-Del mice (Fig. 3G).
3.4. Early alteration of B cell and nuclear signaling in the peripheral blood
are correlated with later inflammation in the kidney in female homozygous
ARE-Del mice
As noted, the cecal microbiome was altered in homozygous ARE-Del
mice, of which changes were much stonger when compared to the
heterozygotes than any sex-differences in these mice. Furthermore,
pathological and serological phenotypes such as loss of marginal zone B
cells and autoantibody production are distinctive between homozygous
and heterozygous ARE-Del mice beyond any sex-differences [7]. Thus,
we compared gene expression profiles in female homozygous vs
heterozygous ARE-Del mice, at different ages and in different tissues to
characterize mechanistic differences. In Fig. 4A, a PCA plot shows
clusters of gene expression data from all 218 samples, as described in
the methods section, based on their similarity. Gene expression profiles
in each tissue were distinctive and separated from other tissues with a
mild effect of age, thus we further analyzed differentially expressed
(DE) genes of female homozygous and heterozygous ARE-Del mice
compared to control littermates in each tissue as shown in Fig. 4B. The
statistical analysis was performed using Partek Genomics Suite 6.6 and
the number of DE genes of female homozygous and heterozygous ARE-
Del mice in each tissue were generated and compared to control lit-
termates with a p-value threshold of 0.05 and ± 2 fold change cut-off.
Up-regulated genes (a fold change ≥2 with a p-value<0.05) were
marked with an orange color, and down-regulated genes (a fold
change ≤ -2 with a p-value<0.05) were marked with a blue color,
respectively. Among these changes, it was notable that DE genes were
highly increased from an early age at 3 weeks, specifically in the blood
(PBMCs) from both female homozygous and heterozygous ARE-Del
mice.
Although the number of DE genes indicate how genes in each tissue
rapidly responded over a time period, mechanism-based analysis also
gives crucial information to understand how these DE genes are
meaningfully connected with mechanistic processes for pathogenic
development. Fig. 4C presents that the number of significantly changed
canonical pathways (p < 0.05) of either up- or down-regulated genes
in PBMCs, spleen, and kidney over age, analyzed by Ingenuity pathway
analysis (IPA). Here, we specifically analyzed differential pathways
between female homozygous vs heterozygous ARE-Del mice to char-
acterize homozygous-specific mechanistic changes which can be con-
nected with homozygous-specific microbial alteration.
As shown in Fig. 4D, the top three canonical pathways for up- or
downregulated genes in the PBMCs and spleen are listed (a-d) and top
ten canonical pathways for upregulated genes in the kidney are also
listed (e-f) in order. Overally, notable changes in PBMCs and spleen
were detectable at 3 weeks of age and particularly include macrophage
activation (data not shown here) and impaired B cell signaling. Fur-
thermore a sequential increase of T cell signaling was detectable in the
kidney from 6 weeks of age, implying that early changes in the per-
ipheral blood immune cells impact later inflammatory responses in the
kidney. The highest top canonical pathways in PBMCs reflected the
finding that nuclear receptor FXR/RXR and LXR/RXR signaling was
increased at 3 weeks (a) and oppositely suppressed at 12 weeks (c). A
similar pattern was detected in PPAR signaling, driven by gene set
enrichment analysis (GSEA) (Fig. 4E). A set of genes related to PPAR
signaling obtained from GSEA databases was increased at 3 weeks of
age and later suppressed at 12 weeks of age in female homozygous ARE-
Del mice compared to control littermates. The kidney had highly up-
regulated canonical pathways that regulate the development of CD4 T
helper cells from 6 weeks of age (e-f). As mentioned before, another
remarkable gene expression change in PBMCs was suppression of B cell
receptor signaling, detectable at 3 weeks of age (b). A similar but
weaker pattern was detectable in the spleen (d) but not in the thymus.
Using flow cytometry analysis, a subpopulation of B cells in the spleen
from female homozygous ARE-Del mice and control littermates at 4
weeks of age were analyzed (Supplemental Fig. 3A). Given that im-
mature B cells (CD21lowCD23low) were higher in ARE-Del mice, while
FO (CD21intCD23int) and marginal zone (MZ) B cells (CD21highCD23low)
were lower in ARE-Del mice compared to control littermates, it is likely
that early suppressed B cell signaling in the gene expression pattern
results in impaired B cell differentiation in the secondary lymphoid
organs.
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3.5. mTOR-autophagy pathway is dysregulated in macrophages at early
ages, as an initial pathogenic mechanism in female homozygous ARE-Del
mice
Given that macrophage depletion by CLL significantly reduces
splenic MZB cells and increases ANA production, we hypothesized that
functional alteration of macrophage at early ages plays a critical role in
B cell differentiation in secondary lymphoid organs and development of
autoantibodies. To predict each activation level of peripheral blood
immune cells, we utilized K-means clustering to sort genes based on
patterns of gene expression (Supplemental Fig. 4). We clustered into 20
gene sets based on their expression patterns over time and analyzed the
most target cells and tissues in each cluster, according to Mouse Gene
Atlas. Consistent with pathway analysis, the pattern with early sup-
pression corresponded to follicular B cell signaling (Supplemental
Fig. 4A). In contrast, the pattern of gene expression revealed early ac-
tivation as well as persistent activation over time that was consistent
with activated macrophage signaling (Supplemental Figs. 4B and 4C),
suggesting that early altered macrophage function is critical for the
disease progression. In addition, dendritic cell signaling gradually in-
creased (Supplemental Fig. 4D), indicating that chronic DC activation
corresponds to pathological development of autoimmune diseases.
Based on our observations, we next focused on evaluating autophagy,
which is known as a critical pathway in macrophages, regulating pha-
gocytosis, antigen processing, metabolic processes and inflammatory
responses. First, we examined mTOR signaling and autophagy-related
genes depending on the age in homozygous ARE-Del mice (Fig. 5A). As
early as 3 weeks, genes regulating mTOR signaling and autophagy were
most affected and dysregulated. To evaluate the dysregulated function
of these pathways, we isolated peripheral macrophages and developed
bone-marrow derived macrophages from female homozygous ARE-Del
mice, in order to examine the formation of autophagosomes in the
presence or absence of the mTOR inhibitor, rapamycin (Fig. 5B and C).
In Fig. 5B, bone-marrow derived macrophages were treated with ra-
pamycin with or without pre-treatment with bafilomycin to inhibit
degradation of LC3-II. LC3-II accumulated in wild type mice upon
treatment of rapamycin, indicating increased autophagy processes upon
suppression of mTOR signaling. However, the LC3-II complex was not
increased in cells from homozygous ARE-Del mice under the same
conditions. We further confirmed the autophagosome formation using
Cyto-ID staining (Fig. 5C). Upon treatment with Rapamycin, autopha-
gosomes stained by green-fluorescent Cyto-ID were increased in bone-
marrow derived macrophages from wild type mice but not homozygous
ARE-Del mice, whereas the basal level of autophagosomes slightly in-
creased in macrophages from homozygous ARE-Del mice compared to
control mice.
To characterize autophagy function in macrophages at a systemic
level, the expression level of macrophage marker genes, including
Marco and Siglec1, were analyzed in blood and tissues over time. They
were highly upregulated in the blood and kidneys at 3 weeks of age,
with such activation being sustained or gradually decreased with age
(Fig. 5D). Utilizing pathway analysis, the data indicates that female
homozygous ARE-Del mice, as compared to heterozygotes, have more
profound alterations of phagosome formation and maturation, and
oxidative phosphorylation at 3 weeks of age (Supplemental Fig. 5).
Consistently, the gene expression profiles support the model that genes
involved in autophagy process were down-regulated in kidney from
homozygous ARE-Del mice, while this pathways were not significantly
changed in the kidney from heterozygous mice (Fig. 5E), thus in-
dicating that levels of IFN-γ can have different effects on host phy-
siology.
3.6. Abnormal thymic B cell development and its effect on central T cell
tolerance in female homozygous ARE-Del mice
DE gene profiles showed that there was a significant increase of
gene expression in the thymus at 12 weeks of age specifically in
homozygous ARE-Del mice (Fig. 4B). Although pathway analysis did
not characterize well top canonical pathways in the thymus, possibly
due to the specificity of thymic gene expression, we noticed that thymic
B cell markers were changed with a similar pattern of DE gene profiles.
Furthermore, CD 19, a surface marker for B cells, gradually increased in
the thymus with age, but not other tissues in female homozygous ARE-
Del mice (Fig. 6A). Seeing that early B cell receptor signaling was highly
suppressed in PBMCs, we further compared expression levels of other B
cell markers and MHC class II molecules in PBMCs and the thymus
depending on the genotype at 3, 6 and 12 weeks of age (Fig. 6B).
Correlated with an early suppressed B cell response in PBMCs, the ex-
pression of B cell markers and MHC II molecules are much higher in the
thymus from female homozygous ARE-Del mice at later ages. Particu-
larly, AIRE, CD40, and CD80 increased along with MHC class II mole-
cules at 12 weeks of age, indicating that abnormal development of
thymic B cells may affect central T cell tolerance [21]. We further
confirmed the increase of B cell marker (B220) in the thymus by im-
munohistochemistry (Supplemental Fig. 3B). In the integrative analysis
of miRNA and mRNA profiles in the thymus, performed by IPA, we
noticed that expression levels of significantly changed (p < 0.05)
miRNA were persistently suppressed and those miRNA that targeted 73
genes were correspondingly increased, matched by age (12 weeks old),
in female homozygous ARE-Del mice (Supplemental Table 1). The most
significantly changed miRNA (p < 0.05, fold change cut offs ± 1.5)
and target mRNAs were listed in Fig. 6C. We performed pathway ana-
lysis of 73 miRNA-mRNA target genes by IPA and top canonical path-
ways include communication between innate and adaptive immune
cells; altered T cell and B cell signaling in rheumatoid arthritis; systemic
lupus erythematosus signaling (Fig. 6D).
4. Discussion
Emerging studies have focused on the interaction between the gut
microbiome alteration (referred as gut dysbiosis hereafter), chronic
inflammation and autoimmune diseases [22–27]. Although the asso-
ciation of chronic inflammation with gut dysbiosis and autoimmune
diseases is well recognized, the mechanistic interactions are not well
Fig. 3. Sex-specific metabolite profiles in homozygous ARE-Del mice. (A) A PCA plot of the metabolites in male or female homozygous ARE-Del mice vs control
littermates. (B) Scatter plot showing the relationship between overall metabolites (Log2 fold changes) from male or female homozygous ARE-Del mice vs control
littermates. Dotted lines point relatively one fold up or down-regulated directions between male vs female homozygous ARE-Del mice. (C) Heatmap of differentially
expressed metabolites (p < 0.05), which were selected from Figure B and presented by log2 fold change. (p < 0.05). (D–E) FAO related metabolites (hex-
anoylglycine and 3-hydroxybutyrate) in male and female homozygous ARE-Del mice compared to control littermates (each group, n = 4–6). Statistical analysis is
performed by Mann Whitney test (**p < 0.001). Sex-different bile acid composition in male and female homozygous ARE-Del mice (F–G). (F) The relative ratio of
bile acids was calculated by comparison of fold changes between male or female homozygous ARE-Del vs control littermates. (G) The relative ratio of tauro-
conjugated vs unconjugated bile acids in male and female ARE-Del−/−mice. CA; cholate, TCA; taurocholate, DCA; deoxycholate, TDCA; taurodeoxycholate, βMCA;
beta-muricholate, TβMCA; tauro-beta-muricholate, CDCA; chenodeoxycholate, TCDCA; taurochenodeoxycholate.
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understood. Strikingly, our data on homo, hetero and WT mice in di-
versity and richness of that cecal microbiome (Fig. 1A) suggests that
chronic expression of IFN-γ has a threshold level to break gut home-
ostasis. Moreover, gut dysbiosis occurred at an early age and is sys-
temically correlated with other pathological mechanistic features found
in homozygous ARE-Del mice. In view of the fact that IFN-γ is a critical
regulator of gut homeostasis against viral and microbial infection [28],
our data indicate that low but chronic expression of IFN-γ has a detri-
mental role in gut homeostasis depending on the expression level and is
pivotal to the pathogenic development of autoimmune diseases.
In addition to gut microbial changes, the metabolic profiles such as
amino acid metabolites reflected strong differences between sexes.
Consistent with this finding, recent evidence suggests that amino acid
metabolism is a major sex-discriminating factor in the liver during
fasting in order to provide a fuel to maintain lipid synthesis in mice
[29]. We further focused on both sex- and genotype-dependent meta-
bolic processes and found that β-hydroxybutyrate and hexanoylglycine
were among the most affected metabolites by both processes (Fig. 3B).
Given that β-hydroxybutyrate, known as 3-hydroxybutyrate (BHBA), is
a indicator for the FAO rate during fasting [30] and hexanoglycine is
also involved in FAO [31], it is expected that FAO plays a critical role in
the pathogenetic development of immune responses. Furthermore, the
level of acylcarnitine is clearly different between male and female ARE-
Del mice. Carnitine is an essential transporter of fatty acid into mi-
tochondria via conversion into acylcarnitine for subsequent mitochon-
drial fatty acid oxidation in human and mice [32]. As the level of cir-
culating acylcarnitine is positively correlated with the rate of FAO upon
fasting condition [33], the different expression level of circulating
acylcarnitine in male vs female ARE-Del mice under fasting conditions
can reflect the activated status of FAO. Due to the fact that FAO is a key
metabolic process to modulate inflammatory responses [34,35], and is
modulated by nuclear receptors such as peroxide proliferator-activated
receptors (PPARs) and liver X receptors (LXRs), interacting with es-
trogen receptors [36], these observations point to the significance of
nuclear receptor signaling in the development of sex-different in-
flammatory responses via modulation of lipid metabolic processes in
ARE-Del mice.
Here we featured that composition of serum bile acids was drama-
tically changed in homozygous ARE-Del as compared to control litter-
mates, particularly in the tauro-conjugated bile acid composition.
Female mice also have a higher induction than male mice. This feature
is consistent with our previous report demonstrating that the increased
level of serum total bile acids (TBA) was significantly detectable in
homozygous but not heterozygous ARE-Del mice, and this pattern is
also female-biased. On the basis that the gut microbiome has a critical
role in the bile acid metabolism in the gut-liver axis, particularly
through nuclear receptor FXR, we further focus on the connection be-
tween FXR and bile acid composition being linked to the gut micro-
biome alteration. Interestingly, the conjugated vs non-conjugated ratio
of tauro-β-muricholic acid noticeably increased in female ARE-Del mice
(Fig. 3G). Tauro-β-muricholic acid is recently identified as a natural
competitive and reversible antagonist of FXR [37] and is known to be
controlled by the gut microbiome, as shown by the observation that the
level of tauro-β-muricholic acid is approximately 10 times higher in bile
from germfree than from conventional rats [38]. Since bile acid
synthesis is under negative feedback control through activation of FXR,
the interplay of the gut microbiome in reducing tauro-β-muricholic acid
(a FXR antagonist in this case) can have profound effects on bile acid
synthesis via FXR [39,40]. Given that gene expression profiles of FXR
signaling were clearly suppressed in the liver as well as in the PBMCs
over time period in homozygous ARE-Del mice and predominantly in
female mice, our data indicate that FXR plays a critical role in bile acid
and lipid metabolism interacting with the gut microbiome in response
to chronic expression of IFNγ, eventually affects liver inflammatory
responses and pathological progression of PBC.
Other additional data also support the hypothesis that the gut mi-
crobiota modulates host metabolites, which further interact with nu-
clear receptor signaling and modulate inflammatory responses in ARE-
Del mice. One of the notable changes is that tryptophan metabolism is
highly altered in homozygous ARE-Del mice, including upregulation of
kynurenine and indolelactate as well as suppression of serotonin, N-
acetyl tryptophan, and tryptophan (Table 1). Kynurenine is an en-
dogenous ligand of the aryl hydrocarbon receptor (AhR) and in-
dolelactic acid is a bacterial metabolite as a ligand of AhR [41].
Emerging evidence suggests that AhR is a critical modulator for in-
flammatory responses and intestinal immunity [42,43] and its activity
is linked to several autoimmune diseases [44,45]. As additional evi-
dence, the plasma level of succinate was differentially changed between
male and female ARE-Del mice compared to control littermates
(Supplemental Fig. 2A). Succinate, involved in the TCA cycle, is known
as a metabolic signal in inflammation. Circulating succinate levels in-
crease upon deletion of nuclear receptor4 group A1 (Nr4a1) and con-
sequently induce Th1/Th17 differentiation [46–48]. Regarding that
obesity-associated gut microbiota increases circulating levels of succi-
nate [49] and female Nr4a1 deficient mice show increased suscept-
ibility to high fat diet-induced obesity [50], sex-different circulating
levels of succinate can be a consequence of the sensitivity to the sup-
pression of Nr4a1. Taken together, our data suggest that nuclear re-
ceptors are integrative modulators of lipid metabolism, inflammation,
and gut microbial homeostasis as a result of chronic expression of IFN-γ.
Given that nuclear receptors crosstalk with sex-hormone signaling
pathways, this feature is also crucial for sex-specific pathogenesis in
autoimmune diseases. Particularly, PPARs play a central role in female-
biased inflammation and autoimmunity depending on the interaction
with sex hormones in immune cells [51,52], and IFN-γ negatively
regulate PPAR gamma expression at the transcription level [53]. No-
tably, gene expression profiling shows that FXR, LXR and PPAR sig-
naling pathways are among the top canonical pathways detected from
Fig. 4. Overall age- and tissue-dependent gene expression profiles in female homozygous and heterozygous ARE-Del mice with control littermates. (A) A PCA plot of
overall gene expression in blood, kidney, spleen, and thymus at 3, 6, 12 weeks in homozygous and heterozygous ARE-Del mice with control littermates. (B)
Comparison of upregulated or downregulated genes in blood, spleen, thymus, and kidney from homozygous and heterozygous ARE-Del mice compared to control
littermates at 3, 6, 12 wks. The total height of each bar indicates the number of genes (orange bar; upregulated genes, blue bar; downregulated genes). S; spleen, K;
kidney, B; blood, T; thymus. (C) Number of canonical pathways in homozygous ARE-Del mice compared to heterozygous ARE-Del mice in blood, spleen, and kidney
at 3, 6, and 12 weeks old. The total height of each bar indicates the number of significant canonical pathways derived from upregulated (orange) or downregulated
(blue) genes in female homozygous ARE-Del mice compared to heterozygotes. (D) The significant number of canonical pathways from Fig. 5A was calculated by –log
(p-value) less than 1.5 (relative to p-value < 0.05). Ratio (red line) refers to the number of genes from the data set divided by the total number of genes according to
the IPA knowledge base. a-f; representative top canonical pathways ordered from the highest one in each group. (E) GSEA plots of PPAR signaling in the blood with a
comparison between 3 and 12 weeks in female homozygous ARE-Del mice. PPAR signaling gene set was derived from the GSEA database, and enrichment was
defined by normalized enrichment score (NES), false discovery rate (FDR) q-value. (For interpretation of the references to color in this figure legend, the reader is
referred to the Web version of this article.)
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the early stage of homozygous ARE Del mice (Fig. 4D). As suggested
that there is a reciprocal negative crosstalk between LXRs and IFN-γ-
stimulated STAT1-dependent transcription [54], and IFN-γ-stimulated
STAT1 activation suppresses FXR transcription [55] in macrophages, it
is expected that IFN-γ negatively modulates FXR, LXRs, and PPARs
expression via the transcriptional suppression of these nuclear re-
ceptors. In addition, sex steroid hormones modulate gut microbiota-
host interaction and nuclear receptors regulate intestinal inflammatory
responses [56,57]. Our observations support the hypotheses that a sex-
different microbial alteration can interact with host nuclear receptor
signaling and vice versa. Thereby, IFN-γ targets a variety of nuclear
receptor signaling and modulates nuclear receptor signaling directly or
indirectly through microbial alterations, resulting in both genotype-as
well as sex-biased pathogenesis in autoimmune diseases.
Homozygous ARE-Del mice specifically have a decrease of the
splenic B cell population [9] and the loss of splenic marginal zone (MZ)
macrophages and B cells [7]. Moreover, the loss of MZBs and anti-
nuclear antibody (ANA) are significantly increased by CLL treatment in
heterozygous ARE-Del mice. Given that marginal zone macrophages
(MZMs) are required for antigen capture by MZBs [58] and depletion of
macrophages by CLL treatment suppresses B cell migration to the fol-
licular perimeter, resulting in the loss of MZBs [59], the current find-
ings support the concept that the antigen-presentation pathways in
macrophages are essential for B cell migration and differentiation. The
uptake of liposomes is targeted by the mononuclear phagocytic system
(MPS), particularly macrophages [60], and liposomal clodronate in-
duces apoptosis when it is released within the phagocytic cells [61].
Regarding that phagocytosis is closely linked to autophagy in its reg-
ulatory mechanisms [62,63], our data reveal that dysregulated autop-
hagy plays a central role in impaired early B cell development and
differentiation. Autophagy, a conserved bulk-degradation process of
intracellular or extracellular components, centrally regulates antigen
presentation and inflammation [64,65], and polymorphisms of autop-
hagy-related genes have been associated with major autoimmune dis-
eases such as SLE and RA [66,67] and inflammatory bowel disease,
contributing to gut microbial homeostasis [68]. Consistent with these
findings, deletion of autophagy-related genes (Atg5) dramatically al-
tered the composition of the gut microbiota in a murine model [69].
Thus, we believe that the dysregulated autophagy process, particularly
in macrophages, has a mechanistic role in the breakdown of B cell self-
tolerance mechanisms as well as gut dysbiosis.
We previously reported that adoptive transfer of CD T cells from
ARE-Del mice into wild type mice markedly increased pathological
phenotypes of PBC as well as the development of germinal center B cells
[8,9], indicating that autoreactive T lymphocytes are key players in
autoimmune diseases in ARE-Del mice. In this aspect, we further focus
on the immune response in the thymus of homozygous and hetero-
zygous ARE-Del mice. According to the recent report that peripheral B
cells migrated to the thymus upon receiving CD40 signaling in the
context of cognate interaction with CD4+ T cells and as such can ex-
press AIRE and upregulate MHC Class II and CD80 expression [21], our
findings imply that B cells, that migrated from the peripheral to thymus
can present self-antigens and enhance central T cell tolerance induc-
tion. Therefore, our data provides a new insight of how early abnormal
macrophage and B cell signaling can affect T cell signaling in the
thymus which can break central T cell tolerance sequentially.
In conclusion, we illustrate how these mechanistic features, re-
sulting from chronic IFN-γ expression, interact with each other at both
system cellular levels to break immune tolerance (Supplemental Fig. 6).
Considering that GC B cells are critical for ANA production in lupus-
prone mice [70] and homozygous ARE-Del mice have strongly biased
GC B cell development [9], understanding the mechanisms to induce
GC B cell-dependent autoantibodies will be pivotal for discriminating
how host immune system is differently impacted by the modest dif-
ferent expression level of IFN-γ (Supplemental Fig. 6A). Although IFN-γ
interplays with Type I IFNs that are critical for sex- and genotype-de-
pendent pathological development in ARE-Del mice [9], it is not well
understood how IFN-γ increases Type I IFN signaling. According to our
findings, we can derive a hypothetical mechanism of how IFN-γ reg-
ulates Type I IFNs, thus interfering with autophagy and nuclear re-
ceptor signaling at a cellular level (Supplemental Fig. 6B). Given that
autophagy intersects with Type I and II IFNs and has a suppressive role
in Type I IFN activation [71], dysregulated autophagy may play a cri-
tical role in Type I IFN production in ARE-Del mice. In support of this
hypothesis, abrogation of autophagy induces Type I IFN production as a
result of impaired DNA-stimulated STING degradation [72,73]. Con-
sidering the fact that nuclear receptors of PPARα and FXR oppositely
modulate FAO as well as autophagy depending on nutrient status in the
liver [74,75] and suppression of PPARγ, LXRs, and RXR signaling by
IFN-γ increases intracellular accumulation of cholesterol [76], we hy-
pothesize that suppression of nuclear receptor signaling produces Type
I IFNs via altered autophagy and lipid metabolism in ARE-Del mice.
In summary, this study illustrates the etiopathological mechanisms
how low but chronic IFN-γ leads to autoimmunity, particularly via host-
gut microbiota and metabolic interactions. Interestingly, distinctive
mechanistic features induced by differential expression level of IFN-γ as
well as sex-specific changes converge into a variety of nuclear receptor
signaling pathways, suggesting that nuclear receptor activities are cri-
tical to modulate immune responses resulting in the development of
autoimmune diseases. Our data also highlight how chronic IFN-γ ex-
pression mechanistically reflects chronic inflammation-mediated auto-
immune diseases, and as such may be a relevant murine model of
chronic inflammation in humans.
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